- Home
- ALRN vs VGI Comparison
ALRN vs VGI Comparison
Compare ALRN & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- VGI
- Stock Information
- Founded
- ALRN 2001
- VGI 2012
- Country
- ALRN United States
- VGI United States
- Employees
- ALRN N/A
- VGI N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- ALRN Health Care
- VGI Finance
- Exchange
- ALRN Nasdaq
- VGI Nasdaq
- Market Cap
- ALRN 76.9M
- VGI 91.4M
- IPO Year
- ALRN 2017
- VGI N/A
- Fundamental
- Price
- ALRN $1.92
- VGI $7.76
- Analyst Decision
- ALRN Strong Buy
- VGI
- Analyst Count
- ALRN 1
- VGI 0
- Target Price
- ALRN $19.00
- VGI N/A
- AVG Volume (30 Days)
- ALRN 92.8K
- VGI 46.0K
- Earning Date
- ALRN 11-14-2024
- VGI 01-01-0001
- Dividend Yield
- ALRN N/A
- VGI 12.66%
- EPS Growth
- ALRN N/A
- VGI N/A
- EPS
- ALRN N/A
- VGI N/A
- Revenue
- ALRN N/A
- VGI N/A
- Revenue This Year
- ALRN N/A
- VGI N/A
- Revenue Next Year
- ALRN N/A
- VGI N/A
- P/E Ratio
- ALRN N/A
- VGI N/A
- Revenue Growth
- ALRN N/A
- VGI N/A
- 52 Week Low
- ALRN $1.61
- VGI $6.68
- 52 Week High
- ALRN $7.42
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- ALRN 29.69
- VGI 31.08
- Support Level
- ALRN $1.85
- VGI $8.00
- Resistance Level
- ALRN $2.38
- VGI $8.18
- Average True Range (ATR)
- ALRN 0.30
- VGI 0.08
- MACD
- ALRN -0.01
- VGI -0.03
- Stochastic Oscillator
- ALRN 6.31
- VGI 0.00
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.